DIL informs about financial results

14 Aug 2018 Evaluate

DIL has informed that the board of Directors of the Company at its meeting held on August 14, 2018, has approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2018 as per Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; to consider and submit consolidated financial results effective from quarter ended June 30, 2018, for the financial year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

327.00 2.05 (0.63%)
23-Jan-2026 09:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.80
Dr. Reddys Lab 1243.50
Cipla 1376.10
Zydus Lifesciences 894.65
Lupin 2149.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×